Joseph Belleau, MD
Allergy & Immunology · Brentwood, TNNPI 1346297371
Payments from drug & device makers
Across 623 payments — averaging $19.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Sanofi$1K
- CSL Behring$1K
- GSK$1K
- Amgen$717
- Pfizer$686
- plus $5K from 25 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 100 | $1,998 |
| Sanofi | 89 | $1,397 |
| CSL Behring | 51 | $1,314 |
| GSK | 65 | $1,086 |
| Amgen | 39 | $717 |
| Pfizer | 43 | $686 |
| Regeneron Healthcare Solutions, Inc. | 25 | $686 |
| Novartis | 37 | $678 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $493 |
| Optinose US, Inc. | 23 | $471 |
| ARS Pharmaceuticals Operations, Inc. | 18 | $467 |
| Kaleo, Inc. | 19 | $406 |
| Genentech USA, Inc. | 15 | $365 |
| Grifols USA, LLC | 15 | $339 |
| AbbVie(2 entities) | 12 | $215 |
| Teva Pharmaceuticals USA, Inc. | 11 | $191 |
| Boehringer Ingelheim | 9 | $150 |
| Alk-abello, Inc | 7 | $137 |
| Hikma Pharmaceuticals USA | 5 | $98 |
| Octapharma USA, Inc. | 4 | $98 |
| Lilly USA, LLC | 2 | $60 |
| Merck | 3 | $43 |
| Greer Laboratories, Inc. | 2 | $40 |
| Eyevance Pharmaceuticals LLC | 2 | $30 |
| Aimmune Therapeutics, Inc. | 2 | $27 |
| Biocryst US Sales Co., LLC | 1 | $24 |
| Shire North American Group Inc | 1 | $22 |
| ADMA Biomanufacturing LLC | 1 | $21 |
| Galderma Laboratories, L.p. | 1 | $19 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
| Phadia US Inc. | 1 | $15 |
How this compares
$12,307 in reported general payments places this provider in the 75th percentile of 79 allergy & immunology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy & immunology in Brentwood
- Jennifer StriblingBrentwood$8K
- Nicholas KolinskyKnoxville$472K
- Karthik KrishnanMaryville$410K
- Tidence PrinceMaryville$303K
- Jay LiebermanMemphis$270K
- Katherine CahillNashville$208K
- Tammy Heinly McCulleyGermantown$165K
- Phillip LiebermanMemphis$131K
- John FahrenholzNashville$124K
- Marc CromieChattanooga$106K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.